These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23496237)

  • 1. Quality of life in patients with toenail onychomycosis.
    Milobratović D; Janković S; Vukičević J; Marinković J; Janković J; Railić Z
    Mycoses; 2013 Sep; 56(5):543-51. PubMed ID: 23496237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of quality of life in patients with toenail onychomycosis by Polish version of an international onychomycosis-specific questionnaire.
    Szepietowski JC; Reich A; Pacan P; Garlowska E; Baran E;
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):491-6. PubMed ID: 17373976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The OnyCOE-t questionnaire: responsiveness and clinical meaningfulness of a patient-reported outcomes questionnaire for toenail onychomycosis.
    Potter LP; Mathias SD; Raut M; Kianifard F; Tavakkol A
    Health Qual Life Outcomes; 2006 Aug; 4():50. PubMed ID: 16911778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naildex: pilot evaluation of an onychodystrophy severity instrument.
    Warshaw EM; Traywick CA; Hoffman AA; Lilly KK; Koshnick RL; Robinson JW; Suwattee P; Foster JK; Chen SC
    Mycoses; 2008 Jan; 51(1):14-20. PubMed ID: 18076590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of toenail dystrophy predicts histologic diagnosis of onychomycosis.
    Walling HW; Sniezek PJ
    J Am Acad Dermatol; 2007 Jun; 56(6):945-8. PubMed ID: 17368630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Onychomycosis in Cameroon: a clinical and epidemiological study among dermatological patients.
    Nkondjo Minkoumou S; Fabrizi V; Papini M
    Int J Dermatol; 2012 Dec; 51(12):1474-7. PubMed ID: 23171013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toenail abnormalities and onychomycosis in chronic venous insufficiency of the legs: should we treat?
    Shemer A; Nathansohn N; Kaplan B; Trau H
    J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):279-82. PubMed ID: 18269594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and mycological features of onychomycosis in central Tunisia: a 22 years retrospective study (1986-2007).
    Dhib I; Fathallah A; Yaacoub A; Zemni R; Gaha R; Said MB
    Mycoses; 2013 May; 56(3):273-80. PubMed ID: 23094998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validity of self-reported nail counts in patients with onychomycosis: A retrospective pilot analysis.
    Cham PM; Chen SC; Grill JP; Warshaw EM
    J Am Acad Dermatol; 2008 Jan; 58(1):136-41. PubMed ID: 17964690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Onychomycosis: A study of self-recognition by patients and quality of life.
    Bunyaratavej S; Pattanaprichakul P; Leeyaphan C; Chayangsu O; Bunyaratavej S; Kulthanan K
    Indian J Dermatol Venereol Leprol; 2015; 81(3):270-4. PubMed ID: 25851764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A health-related quality of life measure for use in patients with onychomycosis: a validation study.
    Lubeck DP; Gause D; Schein JR; Prebil LE; Potter LP
    Qual Life Res; 1999; 8(1-2):121-9. PubMed ID: 10457745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, mycological and histological aspects of white onychomycosis.
    Moreno-Coutiño G; Toussaint-Caire S; Arenas R
    Mycoses; 2010 Mar; 53(2):144-7. PubMed ID: 19389073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of onychomycosis on quality of life.
    Whittam LR; Hay RJ
    Clin Exp Dermatol; 1997 Mar; 22(2):87-9. PubMed ID: 9330072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of toenail onychomycosis among diabetics at a primary care facility in Malaysia.
    Leelavathi M; Azimah MN; Kharuddin NF; Tzar MN
    Southeast Asian J Trop Med Public Health; 2013 May; 44(3):479-83. PubMed ID: 24050080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathological periodic acid-schiff stains of nail clippings as a second-line diagnostic tool in onychomycosis.
    Mayer E; Izhak OB; Bergman R
    Am J Dermatopathol; 2012 May; 34(3):270-3. PubMed ID: 22452952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of onychomycosis on quality of life: development of an international onychomycosis-specific questionnaire to measure patient quality of life.
    Drake LA; Patrick DL; Fleckman P; Andr J; Baran R; Haneke E; Sapède C; Tosti A
    J Am Acad Dermatol; 1999 Aug; 41(2 Pt 1):189-96. PubMed ID: 10426887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The asymmetric gait toenail unit sign.
    Zaias N; Rebell G; Casal G; Appel J
    Skinmed; 2012; 10(4):213-7. PubMed ID: 23008938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nail clipping in onychomycosis and comparison with normal nails and ungual psoriasis.
    Trevisan F; Werner B; Pinheiro RL
    An Bras Dermatol; 2019 Jul; 94(3):344-347. PubMed ID: 31365667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of toenail onychomycosis on patient quality of life.
    Elewski BE
    Int J Dermatol; 1997 Oct; 36(10):754-6. PubMed ID: 9372349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subclinical onychomycosis is associated with tinea pedis.
    Walling HW
    Br J Dermatol; 2009 Oct; 161(4):746-9. PubMed ID: 19558550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.